🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our library of publications showcasing our Gene Circuit Technology Platform. Explore more here: bit.ly/4jKTFFb $SNTI #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

Senti Bio Receives Additional $1.0 Million Tranche from California Institute for Regenerative Medicines (CIRM) Grant for Advancing Clinical Development of SENTI-202 bit.ly/44KaBXW $SNTI #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

The poster we recently presented at AACR is now available on our website: First-in-human, multicenter study of SENTI-202, a CD33/FLT3 selective off-the-shelf logic gated CAR NK cell therapy in hematologic malignancies including AML: Correlative data bit.ly/42Pu1rJ

#JoinUs on Thursday, May 29 for the LIVE! Biotech Investment Webinar hosted by Webull Corporate Connect. Tune in to hear insights directly from #SNTI management. 🕒 Time: 2:40PM ET 🔗 Register now: bit.ly/3YVeBBa $SNTI #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

#HappeningTomorrow, May 29 — join the LIVE! Biotech Investment Webinar hosted by Webull. Hear directly from $SNTI management at 2:40 PM ET on our latest progress in #CellTherapy and #CARNK. 🔗 Register here: bit.ly/3YVeBBa #AML #AcuteMyeloidLeukemia

$SNTI live today at 2:40 PM ET during the LIVE! Biotech Investment Webinar hosted by Webull. Secure your spot now 👉 bit.ly/3YVeBBa #CellTherapy #CARNK #AML #AcuteMyeloidLeukemia

🚨Starting soon! We’ll be live at 2:40 PM ET in the Biotech Investment Webinar hosted by Webull . Don’t miss updates from $SNTI — join us now! 🔗 Last chance to register: bit.ly/3YVeBBa #CellTherapy #CARNK #AML #AcuteMyeloidLeukemia

Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC on Monday, June 9th at 3:00 PM ET bit.ly/3T9S7sH $SNTI #CellTherapy #CARNK #AML #AcuteMyeloidLeukemia

Potential best-in-class Logic-Gated cell therapy pipeline, initially targeting #AML​. $SNTI #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

Senti Biosciences Announces New Employment Inducement Grants bit.ly/3FS8183 $SNTI

The FDA granted Senti Biosciences #OrphanDrugDesignation for SENTI-202 for the treatment of #AcuteMyeloidLeukemia. Their CMO, Dr. Rajangam discusses #WhatThisMeans for their development program. vimeo.com/1094341592/504… #VirtualInvestor #Oncology # Leukemia #AML #CellTherapy

Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 to Treat Acute Myeloid Leukemia bit.ly/4mYsiJU $SNTI #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

At $SNTI, we’re programming gene circuits to unlock the full potential of cell and gene therapies. #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference bit.ly/3TFtRPq $SNTI #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

As we look back on the countless stories of strength and survival, we’re reminded why days like National Cancer Survivors Day matter. At $SNTI, we’re driven by the hope and determination of survivors as we work to bring forward new options in cell and gene therapy. #CellTherapy

Stay up to date on our latest news, clinical progress, and company updates. Sign up for email alerts: bit.ly/3ZVnb39 $SNTI #CellTherapy #CARNK #AcuteMyeloidLeukemia #AML

Senti Bio Participates in Nasdaq Amplify Spotlight Series bit.ly/3HZGrqq $SNTI

Our CEO, Dr. Timothy Lu, joined Nasdaq’s Amplify Spotlight to share how Senti Biosciences is advancing next-gen cell therapies with our Gene Circuit platform. Check it out here: vimeo.com/1093862410/8a3… $SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia Nasdaq

#InCaseYouMissedIt: The FDA has granted #OrphanDrugDesignation for SENTI-202 to treat #AcuteMyeloidLeukemia. Our CMO, Dr. Rajangam, shares insights on #WhatThisMeans for the development program. Catch up here: vimeo.com/1094341592/504… $SNTI #Oncology #Leukemia #AML #CellTherapy

Happy 4th of July! Wishing you a safe and joyful Independence Day.